Senores Pharmaceuticals consolidated net profit rises 83.88% in the June 2025 quarter

Sales rise 63.90% to Rs 130.30 crore
Net profit of Senores Pharmaceuticals rose 83.88% to Rs 19.73 crore in the quarter ended June 2025 as against Rs 10.73 crore during the previous quarter ended June 2024. Sales rose 63.90% to Rs 130.30 crore in the quarter ended June 2025 as against Rs 79.50 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales130.3079.50 64 OPM %26.2226.82 -PBDT32.4816.98 91 PBT26.4913.46 97 NP19.7310.73 84Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jul 24 2025 | 7:35 AM IST
